Current Status
Not Enrolled
Price
Free
Get Started

Global ASCVD Trends and Emerging Strategies

Program Director

Peter Libby, MD

Program Director

Raul D Santos, MD, MSc, PhD

The IAS has developed the worldwide effort aimed at health care professionals to comprehensively address the matter of LDL-C attributable risk in the prevention of Major Adverse Cardiology Events (MACE) and mortality  This will be accomplished through a series of nine (9) videos presented by some of the most recognizable and prominent leaders in cardiology and lipid medicine from across the globe. 

Importantly, the videos will emphasize the translation of current guidelines and evidence into practice approaches that heighten both clinical and patient success.  Every video, based on real-world issues and evidence, will focus on implementing practical physician and patient strategies. 

The videos are presented in
English, but we have added subtitles in four (4) additional languages:  Arabic, Spanish, Portuguese and Chinese.  

            Click on the button of your preferred language below.

ASCVD Square with Title

Pre-Activty Information

Not available

Video 2- Combating Atherosclerosis: Assessing CV Patient Risk for the T2DM Patient

Not available

Video 1 – The History in the Battle of Insulin and Glucagon

Not available

Futuras terapias para o tratamento da dislipidemia (Video 9 – Future Therapies for Dyslipidemia Treatment)

Not available

Uso de inibidores de PCSK9 em pacientes com hipercolesterolemia familiar (Video 8 – Use of PCSK9 Inhibitors in Familial Hypercholesterolemia Patients)

Not available

Video 5 – Impact of Blocking Circulating PCSK9 with Monoclonal Antibodies on Atherogenic Lipoproteins

Not available

影片9 – 血脂异常的未来疗法

Not available

影片8 – 在家族性高胆固醇血症患者中使用PCSK9抑制剂

Not available

影片7 – 急性冠状动脉综合症后,单克隆PCSK9抑制剂早期使用的疗效,可行性和安全性

Not available

影片6 – PCSK9抑制在非常高危患者中的影响以及如何提高成本效益

Not available

影片5 – 利用单克隆抗体阻断PCSK9循环对动脉粥样化脂蛋白的影响

Not available

影片4 – 密集地降低LDL胆固醇的安全性

Not available

影片3 – 预防ASCVD越低的LDL胆固醇越好

Not available

影片2 – 全世界胆固醇控制悲伤和不足的事实

Not available

影片1 – LDL胆固醇作为ASCVD病因的证据

Not available

Futuras terapias para el tratamiento de la dislipidemia (Video 9 – Future Therapies for Dyslipidemia Treatment)

Not available

Uso de inhibidores de PCSK9 en pacientes con hipercolesterolemia familiar (Video 8 – Use of PCSK9 Inhibitors in Familial Hypercholesterolemia Patients)

Not available

Eficacia, viabilidad y seguridad del uso temprano de inhibidores monoclonales de PCSK9 después de un síndrome coronario agudo (Video 7 – Efficacy, Feasibility and Safety of Early Use of Monoclonal PCSK9 Inhibitors After an Acute Coronary Syndrome)

Not available

Impacto de la inhibición de PCSK9 en pacientes de muy alto riesgo y cómo aumentar la rentabilidad (Video 6 – Impact of PCSK9 Inhibition in Very High-Risk Patients and How to Increase Cost Effectiveness)

Not available

Impacto del bloqueo de la PCSK9 circulante con anticuerpos monoclonales sobre las lipoproteínas aterogénicas (Video 5 – Impact of Blocking Circulating PCSK9 with Monoclonal Antibodies on Atherogenic Lipoproteins)

Not available

Seguridad de la reducción intensiva de LDL-C (Video 4 – Safety of Intensive LDL-C Reduction)

« » page 1 / 9